Showing results (31-40 of 77) with videos related to
Sort By:
Pageof 8
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|July 31, 2024
[Influence of the Use of a Closed System Drug Transfer Device on the Preparation Time of Anticancer Drugs]Toshihisa Nakashima, Kana Tsukiji, Akiko Kubo, et al.Diagnostic Cytopathology|January 22, 2010
Improving the diagnostic accuracy of thyroid follicular neoplasms: cytological features in fine-needle aspiration cytologyJunko Maruta, Hironobu Hashimoto, Yuri Suehisa, et al.Diagnostic Cytopathology|September 9, 2014
Value of thyroid specific peroxidase and Ki-67 stains in preoperative cytology for thyroid follicular tumorsJunko Maruta, Hironobu Hashimoto, Hiroto Yamashita, et al.Case Reports in Oncology|August 7, 2018
Tolerability and Efficacy of Neoadjuvant Chemotherapy with a Tri-Weekly Interval Methotrexate, Doxorubicin, Vinblastine, and Cisplatin Regimen for Patients with Locally Advanced Bladder CancerSatoko Arai, Tomohiko Hara, Yoshiyuki Matsui, et al.Asia-Pacific Journal of Clinical Oncology|July 11, 2018
Cyclophosphamide-induced hemorrhagic cystitis in young patients with solid tumors: A single institution studyYoshimasa Saito, Tadashi Kumamoto, Miki Shiraiwa, et al.International Journal of Hematology|July 14, 2020
Nausea and vomiting during post-transplantation cyclophosphamide administrationToshihisa Nakashima, Yoshihiro Inamoto, Ayumu Ito, et al.International Journal of Hematology|January 28, 2022
Differences in kinetics of tacrolimus concentration after letermovir discontinuation by type of concomitant azole antifungalToshihisa Nakashima, Yoshihiro Inamoto, Jun Aoki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 17, 2020
Randomized, Double-Blind, Placebo-Controlled Phase Ⅱ Study on the Efficacy and Safety of Vitamin K1 Ointment for Cetuximab or Panitumumab-Induced Acneiform Eruptions-VIKTORIA StudyHironobu Hashimoto, Satoru Iwasa, Takako Yanai-Takahashi, et al.Anticancer Research|February 11, 2014
The feasibility of a short bevacizumab infusion in patients with metastatic colorectal cancerTetsuji Terazawa, Hitoshi Nishitani, Ken Kato, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 11, 2018
Risk factors associated with chemotherapy-induced nausea and vomiting in the triplet antiemetic regimen including palonosetron or granisetron for cisplatin-based chemotherapy: analysis of a randomized, double-blind controlled trialDaiki Tsuji, Kenichi Suzuki, Yohei Kawasaki, et al.Pageof 8